As of 2026-10-09, the Relative Valuation of Medexus Pharmaceuticals Inc (MDP.TO) is 4.87 CAD. This relative valuation is based on P/E multiples. With the latest stock price at 4.87 CAD, the upside of Medexus Pharmaceuticals Inc based on Relative Valuation is 0.0%.
The range of the Relative Valuation is 4.87 - 4.87 CAD.
| Range | Selected | |
| Trailing P/E multiples | 65.2x - 65.2x | 65.2x |
| Forward P/E multiples | 44.7x - 44.7x | 44.7x |
| Fair Price | 4.87 - 4.87 | 4.87 |
| Upside | -0.0% - 0.1% | 0.0% |
| Date | P/E |
| 2026-10-07 | 65.16 |
| 2026-10-06 | 64.62 |
| 2026-10-05 | 65.56 |
| 2026-10-02 | 63.15 |
| 2026-10-01 | 65.83 |
| 2026-09-30 | 66.90 |
| 2026-09-29 | 66.90 |
| 2026-09-28 | 68.50 |
| 2026-09-25 | 68.50 |
| 2026-09-24 | 67.43 |
| 2026-09-23 | 67.83 |
| 2026-09-22 | 69.44 |
| 2026-09-21 | 68.10 |
| 2026-09-18 | 67.57 |
| 2026-09-17 | 67.30 |
| 2026-09-16 | 66.90 |
| 2026-09-15 | 65.96 |
| 2026-09-14 | 67.03 |
| 2026-09-11 | 67.97 |
| 2026-09-10 | 67.03 |
| 2026-09-09 | 67.97 |
| 2026-09-08 | 67.97 |
| 2026-09-04 | 67.70 |
| 2026-09-03 | 68.23 |
| 2026-09-02 | 69.97 |
| 2026-09-01 | 69.97 |
| 2026-08-31 | 70.11 |
| 2026-08-28 | 67.70 |
| 2026-08-27 | 68.64 |
| 2026-08-26 | 69.30 |
| 2026-08-25 | 68.90 |
| 2026-08-24 | 69.17 |
| 2026-08-21 | 68.77 |
| 2026-08-20 | 67.03 |
| 2026-08-19 | 67.83 |
| 2026-08-18 | 68.90 |
| 2026-08-17 | 70.11 |
| 2026-08-14 | 71.45 |
| 2026-08-13 | 72.92 |
| 2026-08-12 | 71.85 |
| 2026-08-11 | 70.91 |
| 2026-08-10 | 66.36 |
| 2026-08-07 | 67.70 |
| 2026-08-06 | 66.63 |
| 2026-08-05 | 66.50 |
| 2026-08-04 | 66.76 |
| 2026-07-31 | 67.16 |
| 2026-07-30 | 65.29 |
| 2026-07-29 | 63.95 |
| 2026-07-28 | 64.76 |